DSP and type 1 diabetes mellitus: This demyelination is related to differing clinical features, namely, more impaired glycemic control (mean HbA1C of 9.6%±2.4%) in type 1 diabetes patients compared to the axonal form of DSP (mean HbA1C of 7.5%±1.1).